CAS: 920022-47-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | RO5028442 REF: IN-DA01DUAACAS: 920022-47-5 | 98% | To inquire | Tue 07 Jan 25 |
 | RG7713 REF: TM-T4141CAS: 920022-47-5 | 99.74% | 59.00 €~717.00 € | Mon 13 Jan 25 |
 | RG7713 REF: 3D-VLB02247CAS: 920022-47-5 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA01DUAA
| 1mg | 230.00 € | ||
| 5mg | 570.00 € | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
RG7713
CAS:920022-47-5
RG7713 (RO 5028442) has been used in trials studying Autistic Disorder.
Formula:
C25H28ClN3O2
Purity:
99.74%
Color and Shape:
Solid
Molecular weight:
437.96
Ref: TM-T4141
| 1mg | 59.00 € | ||
| 5mg | 117.00 € | ||
| 10mg | 196.00 € | ||
| 25mg | 332.00 € | ||
| 50mg | 495.00 € | ||
| 100mg | 717.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
RG7713
Controlled ProductCAS:920022-47-5
RG7713 is an investigational drug that belongs to the class of cytochrome P450 3A4 (CYP3A4) …
Formula:
C25H28ClN3O2
Purity:
Min. 95%
Molecular weight:
437.96 g/mol
Ref: 3D-VLB02247
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
